Cliff’s Take: Americans In Wait And See Mode

Most still think a return our pre-COVID lives is a distant reality.
Cliff's Take banner

 

As the vaccine rollout speeds up, are we finally seeing some light at the end of the tunnel? We just might be.

To be clear, we aren’t out of the woods yet. But at least we know what needs to happen next. It’s simple, right? The faster we can get to herd immunity, or the point when enough people have been inoculated to stop the spread of the virus, the faster we can get back to normal.

We even have some idea of when that might be.  It could be as early as next fall, by official estimates. Some encouraging signs. The 7-day moving average of doses administered is now around 1.3 million, a huge leap from just under 300,000 at the end of December.

If the pace keeps up or even improves, we could be on our way to reemerging into the world happy and carefree. 

In the meantime, don’t underestimate American resilience. Most Americans have settled in for the long haul.  But we are all antsy for greater human interaction in open spaces.

Below are some of the week’s data highlights:

  1. Smooth sailing. For Biden, so far, so good. Partisan differences aside, Americans are happy with how Biden is handling his first few days in office. Ultimately, he will be judged on whether he can corral the pandemic – making the vaccine distribution process all important. Biden Feb 2-3 approval rating

     

  2. 50/50. Biden promised to deliver 100 million vaccines in his first 100 days in office. Ambitious? Perhaps not, Biden’s own administration acknowledges as much.  Even so, Americans are divided on whether Biden will be able to deliver.  The proof will be in the pudding. First 100 days

     

  3. Vaccine boondoggle. Vaccine rollout was initially rocky. Things have sped up since. But Americans aren't exactly finding it easy to figure out where and how to get vaccines. Burdening the elderly most of all. Ease of accessing vaccine information

     

  4. Slow Burn. Most Americans are a practical lot.  Most think we won't be back to some semblance of pre-COVID normal until at least summer’s end.  Uncertainty is COVID-normal. Return to normal

     

  5. Travel maybe yes, maybe no. Many have cash to burn, but little fun out there in our COVID world. No movies; no restaurants; no events; no concerts—not much fun. When this is all over, many plan to travel; just as many others have no special plans. Our divided America! What Americans plan to do post pandemic

     

As always, be safe, be sane.

For more information, please contact:

Clifford Young
President, U.S.
Public Affairs
+1 202 420-2016
[email protected]

For more information on COVID-19 please click here

About Ipsos

Ipsos is now the third largest market research company in the world, present in 90 markets and employing more than 18,000 people.

Our research professionals, analysts and scientists have built unique multi-specialist capabilities that provide powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data coming from our surveys, social media monitoring, and qualitative or observational techniques.

“Game Changers” — our tagline — summarizes our ambition to help our 5,000 clients to navigate more easily our deeply changing world.

Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

The author(s)

Related news